Scholarlink

Background <p>The inflammatory response associated with COVID-19 varies with sex, potentially affecting disease outcomes. Males have a higher risk of complications compared to females, requiring an evaluation of differences in inflammatory response severity based on sex.</p> Objective <p>To compare clinical data, biochemical biomarkers, and outcomes among hospitalized COVID-19 patients in Latin America and the Caribbean (LA&amp;C) based on sex and to perform a cluster analysis of biomarker profiles for both sexes.</p> Methods <p>This prospective, multicenter observational registry made by the Inter-American Council of Heart Failure and Pulmonary Hypertension of the Inter-American Society of Cardiology included hospitalized COVID-19 patients from 44 hospitals in 14 countries in LA&amp;C between May 1, 2020, and June 30, 2021.</p> Results <p>Of 3,260 patients (1,201 females and 2,059 males), males had higher C-reactive protein and ferritin levels, while females had higher natriuretic peptides and d-dimer levels. Males had more cardiovascular complications (acute coronary syndrome [3.3% vs. 2.2%], decompensated heart failure [8.9% vs. 7.8%], pulmonary embolism [4.4% vs. 2.9%]), intensive care unit (ICU) admissions (56.9% vs. 47.7%), and overall mortality (27.5% vs. 22.1%). Cluster analysis identified three groups: one with normal-range biomarkers but elevated ferritin, one with coagulation abnormalities, and one with an inflammatory profile linked to renal injury and increased non-cardiovascular mortality.</p> Conclusions <p>In the LA&amp;C population hospitalized with COVID-19, males had higher inflammatory biomarker levels, correlating with increased cardiovascular complications and mortality. The cluster with an inflammatory profile showed higher non-cardiovascular mortality, while clusters with elevated ferritin levels were associated with increased ICU admissions.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Biochemical differences based on sex and clusters of biomarkers in patients with COVID-19: analysis from the CARDIO COVID 19–20 registry

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年3月5日

查看全文
  • Frank Cañón-Estrada,
  • Juan Andrés Muñoz-Ordoñez,
  • Manuela Escalante-Forero,
  • Yorlany Rodas,
  • Andrea Alejandra Arteaga-Tobar,
  • Valeria Azcarate-Rodriguez,
  • Eduardo Perna,
  • Iván Mendoza,
  • Fernando Wyss,
  • José Luis Barisani,
  • Mario Speranza,
  • Walter Alarco,
  • Juan Carlos Ortega,
  • Andrés Ulate,
  • Jessica Mercedes,
  • Daniel Quesada Chaves,
  • Paola Oliver,
  • Andrea Valencia-Orozco,
  • Mario Miguel Barbosa,
  • Hoover León-Giraldo,
  • Noel Alberto Flórez,
  • Juan Esteban Gómez-Mesa,
  • Maria Lorena Coronel,
  • Alejandra Ines Christen,
  • Paula Silva,
  • Juan Martin Brunialti,
  • Pedro Schwartzmann,
  • Luis Carlos Santana Passos,
  • Estevão Lanna Figueiredo,
  • Carlos Eduardo Montenegro,
  • Franco Appiani Florit,
  • Ricardo Enrique Larrea Gómez,
  • Fernando Verdugo Thomas,
  • Iván Criollo,
  • Ricardo Ramírez Ramírez,
  • Víctor Rossel,
  • Julián Lugo,
  • Hugo Fernando Fernández,
  • Maria Juliana Rodríguez,
  • Andrés Buitrago,
  • Noel Flórez,
  • Juan Isaac Ortíz,
  • William Millán Orozco,
  • Clara Inés Saldarriaga,
  • Daniel Quesada,
  • Sylvia Sandoval,
  • Liliana Patricia Cárdenas Aldaz,
  • Marlon Aguirre,
  • Freddy Pow Chong,
  • Armando Alvarado,
  • Daniel Sierra,
  • Alexander Romero,
  • Miguel Quintana,
  • Felipe Nery Gervacio Fernández,
  • Roger Martín Correa,
  • Francisco Chávez Sol Sol,
  • Wilbert German Yabar Galindo,
  • Claudia Almonte,
  • Cesar Herrera,
  • Igor Morr,
  • Eglee Castillo

摘要

Background

The inflammatory response associated with COVID-19 varies with sex, potentially affecting disease outcomes. Males have a higher risk of complications compared to females, requiring an evaluation of differences in inflammatory response severity based on sex.

Objective

To compare clinical data, biochemical biomarkers, and outcomes among hospitalized COVID-19 patients in Latin America and the Caribbean (LA&C) based on sex and to perform a cluster analysis of biomarker profiles for both sexes.

Methods

This prospective, multicenter observational registry made by the Inter-American Council of Heart Failure and Pulmonary Hypertension of the Inter-American Society of Cardiology included hospitalized COVID-19 patients from 44 hospitals in 14 countries in LA&C between May 1, 2020, and June 30, 2021.

Results

Of 3,260 patients (1,201 females and 2,059 males), males had higher C-reactive protein and ferritin levels, while females had higher natriuretic peptides and d-dimer levels. Males had more cardiovascular complications (acute coronary syndrome [3.3% vs. 2.2%], decompensated heart failure [8.9% vs. 7.8%], pulmonary embolism [4.4% vs. 2.9%]), intensive care unit (ICU) admissions (56.9% vs. 47.7%), and overall mortality (27.5% vs. 22.1%). Cluster analysis identified three groups: one with normal-range biomarkers but elevated ferritin, one with coagulation abnormalities, and one with an inflammatory profile linked to renal injury and increased non-cardiovascular mortality.

Conclusions

In the LA&C population hospitalized with COVID-19, males had higher inflammatory biomarker levels, correlating with increased cardiovascular complications and mortality. The cluster with an inflammatory profile showed higher non-cardiovascular mortality, while clusters with elevated ferritin levels were associated with increased ICU admissions.